STOCK TITAN

IQVIA (IQV) executive granted 26,088 stock appreciation rights

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IQVIA Holdings Inc. reported that executive W. Richard Staub, President of Research & Development Solutions, received a grant of stock appreciation rights covering 26,088 shares of common stock on February 9, 2026. These rights have a $192.67 exercise price and vest in three equal annual installments beginning February 9, 2027.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
STAUB W RICHARD

(Last) (First) (Middle)
C/O IQVIA HOLDINGS INC.
2400 ELLIS ROAD

(Street)
DURHAM NC 27703

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IQVIA HOLDINGS INC. [ IQV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right $192.67 02/09/2026 A 26,088 (1) 02/09/2036 Common Stock 26,088 $0 26,088 D
Explanation of Responses:
1. This stock appreciation right vests in three annual installments beginning on February 9, 2027.
Remarks:
President, Research & Development Solutions
/s/ Matthew Gilmartin, Attorney-in-Fact for W. Richard Staub 02/11/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did IQVIA (IQV) report for W. Richard Staub?

The company reported a grant of stock appreciation rights to executive W. Richard Staub. He received rights linked to 26,088 shares of IQVIA common stock, recorded as a derivative acquisition rather than an open-market purchase or sale, according to the Form 4 filing.

How many IQVIA stock appreciation rights were granted to W. Richard Staub?

W. Richard Staub was granted 26,088 stock appreciation rights. Each right is tied to one share of IQVIA common stock, giving him potential future value based on stock price gains above the specified exercise price set in the award.

What is the exercise price of W. Richard Staub’s IQVIA stock appreciation rights?

The stock appreciation rights granted to W. Richard Staub have an exercise price of $192.67 per underlying share. Any future value from the award depends on IQVIA’s stock trading above this exercise price when the rights are exercised.

When do W. Richard Staub’s IQVIA stock appreciation rights vest?

The stock appreciation rights vest in three annual installments beginning on February 9, 2027. This means portions of the 26,088 rights become exercisable each year over a three-year period, as described in the Form 4 footnote.

How many IQVIA derivative securities does W. Richard Staub hold after this grant?

After this transaction, W. Richard Staub beneficially owns 26,088 stock appreciation rights directly. This entire amount reflects the newly granted derivative position reported in the Form 4, with no additional derivative holdings listed in the provided data.

Is W. Richard Staub’s IQVIA stock appreciation right grant a direct or indirect holding?

The Form 4 shows the 26,088 stock appreciation rights as a direct holding. The ownership code is listed as “D,” and there is no indication that the award is held through a separate entity or indirect ownership structure.

Iqvia Hldgs Inc

NYSE:IQV

IQV Rankings

IQV Latest News

IQV Latest SEC Filings

IQV Stock Data

30.05B
168.60M
1.05%
102.1%
2.9%
Diagnostics & Research
Services-commercial Physical & Biological Research
Link
United States
DURHAM